On June 28, 2012, the most significant scientific breakthrough of the first quarter of the 21st century was announced to the ...

Attempting to cash in on what's likely to be a relatively short-lived mania isn't a good idea for most investors most of the ...

From the 2010s to the present, the existing technologies in the clinic and operating room have been improved with the goals ...

Scientists are hoping to use genetic engineering to reduce the transmission of Lyme disease. The scientists' target is not the deer or the ticks often associated with the disease; it's wild mice.

After axing a wide swath of federal research projects and grants, a recent slew of awards offers a glimpse into the kinds of ...

As the industry loses one of its key female leaders in GSK CEO Emma Walmsley, BioSpace profiles the women leading the ...

The total market capitalization of China’s publicly listed biotech firms has reached $1.5 trillion, second only to that of the United States. As China surges, many traditional American strengths have ...

Modern medicine can mend bones, replace organs and extend life — but what does it do for the human spirit? In her new column, ...

We came across a bullish thesis on Nuvation Bio Inc. on wallstreetbets subreddit by asagi_lumina. In this article, we will summarize the bulls’ thesis on NUVB.

With the global AI market set to reach $4.8 trillion by 2033 (UNCTAD), the race to deploy AI for critical sectors has never ...